Expanding Access to Opioid Addiction Treatment Programs Participating BBI treatment provider partners include: Family Health Centers of Baltimore 410-354-2000 631 Cherry Hill Rd., 21225 Next Passage 410-728-8901 2901 Druid Park Dr., 21215 Partners in Recovery 443-573-8672 2225 N. Charles St., 21218 Powell Recovery Center 410- 276-1773 14 S. Broadway, 21231 Sinai Hospital 410-601-4633 2401 W. Belvedere Ave., 21215 Total Health Care 410-383-7197 1501 West Saratoga St., 21223 Tuerk House 410-233-0684 730 Ashburton St., 21216 Universal Counseling Services 410-752-5525 122 Weber St., 21230 Partners University of Maryland Alcohol and Drug Abuse Program 410-328-0126 630 W. Fayette St., 21201 Pathways In addition, the BBI partners with a number of physicians in the community who prescribe buprenorphine through their office practices. A listing can be obtained by contacting Baltimore HealthCare Access Addiction Outreach Services at 410-649-0529. Programs Baltimore Buprenorphine Initiative Baltimore Substance Abuse Systems, Inc. One North Charles Street, Suite 1600 Baltimore, MD 21201-3718 For more information about the BBI contact: Baltimore Substance Abuse Systems 410-637-1900 www.bsasinc.org Expanding Access to Opioid Addiction Treatment Pathways Step 1 The Baltimore Buprenorphine Initiative (BBI) is an effort in Baltimore City aimed at expanding access to treatment for opioid addicted individuals using the medication buprenorphine. Buprenorphine can be prescribed by certified physicians and is a covered service by third party payers, including Medical Assistance and Maryland’s Primary Adult Care Program. The BBI promotes individualized, patientcentered buprenorphine therapy in conjunction with behavioral treatment with a goal of recovery from opioid addiction. The model promotes a continuum of care that includes an outpatient treatment regimen, medication induction, as well as maintenance and stabilization in the medical care system. Step 2 Partners Patient starts buprenorphine in their choice of one of the following options: Outpatient Treatment Residential Treatment Physician Office Patient receives assistance in obtaining health insurance and other needed services to promote stabilization and recovery. The Baltimore Buprenorphine Initiative (BBI) is a joint program of Baltimore Substance Abuse Systems, Inc. (BSAS), Baltimore HealthCare Access, Inc. (BHCA) and the Baltimore City Health Department (BCHD) launched in October of 2006. Each of the following lead agencies along with our treatment provider partners plays a critical role in the development and success of the BBI. Baltimore Substance Abuse Systems, Inc. (BSAS) – BSAS is the substance abuse treatment and prevention authority for Baltimore City. BSAS oversees the BBI including the development of quality improvement efforts and outcomes reporting. BSAS also develops contracts with substance abuse treatment programs and supports their work in the BBI. altimore HealthCare Access, Inc. (BHCA) – BHCA B provides health education, care coordination, outreach, and eligibility determination for a variety of public insurance programs available to Baltimore City residents. BHCA treatment advocates who work with patients, treatment center staff and community physicians to facilitate patients’ access to health insurance and other benefits, and assist patients in transferring to the medical care system. Baltimore City Health Department (BCHD) – BCHD promotes free online physician buprenorphine certification training and assists in expanding the number of participating physicians in the BBI. Step 3 Insured, stable patient transfers to a community physician for continuing buprenorphine treatment and space becomes available for a new patient.